Traws Pharma (TRAW) awards 14,150 stock options to director Cautreels
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Traws Pharma, Inc. director Werner Cautreels received a grant of stock options to acquire 14,150 shares of common stock at an exercise price of $0.68 per share. The options, granted on July 9, 2026 under the 2021 Incentive Compensation Plan, vest 100% after one year and expire on July 9, 2036, leaving him holding options for 14,150 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
CAUTREELS WERNER
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 14,150 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 14,150 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Stock options granted: 14,150 options
Exercise price: $0.68 per share
Underlying common shares: 14,150 shares
+2 more
5 metrics
Stock options granted
14,150 options
Grant to director Werner Cautreels on July 9, 2026
Exercise price
$0.68 per share
Exercise price of director stock option award
Underlying common shares
14,150 shares
Common stock underlying granted options
Expiration date
July 9, 2036
End of exercise period for stock option grant
Options held after grant
14,150 options
Total derivative holdings reported following the transaction
Key Terms
Stock Option (right to buy), exercise price, 2021 Incentive Compensation Plan, vesting
4 terms
Stock Option (right to buy) financial
"Security title listed as Stock Option (right to buy)"
exercise price financial
"Conversion or exercise price of $0.6800 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
2021 Incentive Compensation Plan financial
"Awarded under the Issuer's 2021 Incentive Compensation Plan"
vesting financial
"Stock options under this award will vest 100% on the first anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What stock options did Traws Pharma (TRAW) grant to director Werner Cautreels?
Werner Cautreels received a grant of 14,150 stock options to purchase Traws Pharma common shares. The options were awarded on July 9, 2026 as director compensation under the company’s 2021 Incentive Compensation Plan.
What is the exercise price of Werner Cautreels’ new Traws Pharma (TRAW) stock options?
The granted stock options have an exercise price of $0.68 per share. This means Cautreels can buy up to 14,150 shares of Traws Pharma common stock at $0.68 once the options are vested and exercisable.
When do Werner Cautreels’ Traws Pharma (TRAW) stock options vest and expire?
The stock options vest 100% on the first anniversary of the July 9, 2026 grant date. They have an expiration date of July 9, 2036, giving Cautreels a 10-year window after grant to exercise once vested.
How many Traws Pharma (TRAW) options does Werner Cautreels hold after this grant?
Following the reported grant, Werner Cautreels holds stock options covering 14,150 shares of Traws Pharma common stock directly. This reflects the full amount of the July 9, 2026 award reported in the Form 4.
Was Werner Cautreels’ Traws Pharma (TRAW) option grant an open-market transaction?
No, the transaction was a grant of stock options as director compensation, not an open-market trade. The options were awarded by Traws Pharma’s compensation committee under the 2021 Incentive Compensation Plan at an exercise price of $0.68 per share.